Replies to post #33269 on Endonovo Therapeutics Inc (ENDV)

[Biotech_Tradez]

BUYER BEWARE: New Target Stock Price is $0.0001

Given that Trillium has the ability to convert at 50% discount to market their next conversions will be at $0.0001 or par value. As was predicted in my post below, the market price converges toward the conversion price and following conversions is driven down 50%, essentially it is a death spiral.

My other warning is that this company only has 2.5 billion authorized shares and is already at north of 800 million shares before we get conversions. I also want to point out that I have a very strong hunch that the CEO will give himself a massive bonus in the form of shares as soon as the stock price reaches par value ($0.0001). I predict somewhere in the neighborhood of $50,000 of stock at par value or 500 million shares before he decides to reverse the stock and repeat this scam as he has already done this to shareholders.

So my warning and predictions are as follows:

1.) Stock price goes to $0.0001 or less
2.) CEO gives himself a large bonus at par value or less (maybe 500 million shares)
3.) Reverse stock split at 1 for 1,000 like the last time.

You have been warned. Please feel free to post this as a sticky.